BTIG‘s Heathcare Investment Banking division has added Mikhail Keyserman, CMT, CFTe, as managing director and biotechnology specialist. In his new role, Keyserman will focus on identifying investment banking and capital markets opportunities across the biotech industry.

Prior to this new role, Keyserman served as a managing director and senior healthcare strategy and franchise sales specialist with BTIG. During his time in this role he focused on building relationships with CIOs, portfolio managers and analysts while delivering actionable trading ideas and promoting the firm’s corporate access program.

“Since joining the firm, Mikhail has leveraged his extensive relationships with corporate leadership teams and institutional investors across the capital markets spectrum to drive adoption of our healthcare platform,” commented Matt Clark, managing director, head of BTIG Investment Banking. “We are very excited about the energy and expertise that Mikhail will bring to our healthcare banking practice and look forward to his contributions.”